The global market for Prenatal Diagnostics is estimated at US$6.1 Billion in 2023 and is projected to reach US$14.2 Billion by 2030, growing at a CAGR of 12.7% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
The growth of prenatal diagnostics is driven by advancements in technology and increased awareness of their benefits. Enhanced imaging techniques and genetic testing capabilities have significantly improved the accuracy and reliability of prenatal diagnostics. The integration of artificial intelligence (AI) and machine learning in these processes further refines diagnostic precision, enabling earlier and more accurate detection of potential issues. Additionally, the rising demand for personalized healthcare and preventive medicine has led to broader adoption of prenatal diagnostic techniques. Supportive regulatory frameworks, increased availability of non-invasive options, and improved patient education have also contributed to the expansion of these services. As technology continues to evolve, the scope of prenatal diagnostics is expected to broaden, providing even more comprehensive insights into fetal health and facilitating better outcomes for both mothers and their babies.
The growth of prenatal diagnostics is driven by advancements in technology and increased awareness of their benefits. Enhanced imaging techniques and genetic testing capabilities have significantly improved the accuracy and reliability of prenatal diagnostics. The integration of artificial intelligence (AI) and machine learning in these processes further refines diagnostic precision, enabling earlier and more accurate detection of potential issues. Additionally, the rising demand for personalized healthcare and preventive medicine has led to broader adoption of prenatal diagnostic techniques. Supportive regulatory frameworks, increased availability of non-invasive options, and improved patient education have also contributed to the expansion of these services. As technology continues to evolve, the scope of prenatal diagnostics is expected to broaden, providing even more comprehensive insights into fetal health and facilitating better outcomes for both mothers and their babies.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Non-Invasive Test segment, which is expected to reach US$10.6 Billion by 2030 with a CAGR of a 15.2%. The Invasive Test segment is also set to grow at 7.1% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $1.6 Billion in 2023, and China, forecasted to grow at an impressive 17.2% CAGR to reach $3.6 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Prenatal Diagnostics Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Prenatal Diagnostics Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Prenatal Diagnostics Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as ANGLE Plc, Berry Genomics Co. Ltd., BGI Genomics, and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 43 Featured):
- ANGLE Plc
- Berry Genomics Co. Ltd.
- BGI Genomics
- F. Hoffmann-La Roche Ltd.
- Hologic Inc.
- Illumina Inc.
- Laboratory Corporation of America® Holdings
- Lifecodexx AG
- Natera Inc.
- Quest Diagnostics Inc.
- Ravgen Inc.
- Sequenom Inc.
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISCANADAITALYSPAINRUSSIAREST OF EUROPESOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
UNITED KINGDOM
ASIA-PACIFIC
AUSTRALIA
INDIA
LATIN AMERICA
MIDDLE EAST
AFRICA
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- ANGLE Plc
- Berry Genomics Co. Ltd.
- BGI Genomics
- F. Hoffmann-La Roche Ltd.
- Hologic Inc.
- Illumina Inc.
- Laboratory Corporation of America® Holdings
- Lifecodexx AG
- Natera Inc.
- Quest Diagnostics Inc.
- Ravgen Inc.
- Sequenom Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 194 |
| Published | November 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 6.1 Billion |
| Forecasted Market Value ( USD | $ 14.2 Billion |
| Compound Annual Growth Rate | 12.7% |
| Regions Covered | Global |
